Literature DB >> 19609733

Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.

Christopher R McCartney1, Susan K Blank, John C Marshall.   

Abstract

Subsequent to suppression of LH (GnRH) pulse frequency by progesterone (P) and estradiol (E(2)), LH pulse frequency remains slow for 7 days after P withdrawal if mid-luteal E(2) concentrations are maintained. This may reflect an ability of E(2) to potentiate the suppressive effects of low P levels. We explored this notion in a similar experimental paradigm by administering a P-receptor antagonist (mifepristone) after P withdrawal while continuing E(2). Studies were performed in seven ovulatory, non-obese women. Transdermal E(2) (0.2 mg/day) and oral micronized P (100 mg every 8 h) were started within 24 h of the LH surge and continued for 10 days. Subjects then underwent a 13-h blood sampling protocol for determination of LH pulse characteristics and various hormone concentrations. Oral P was then discontinued, and oral mifepristone (50, 100, or 200 mg daily) and transdermal E(2) (0.2 mg/day) were administered for 7 days, after which the above sampling protocol was repeated. Results with all mifepristone doses were similar and therefore pooled. Mean LH, LH amplitude, and mean FSH markedly decreased after 7 days of mifepristone, but LH pulse frequency did not change (3.3 +/- 1.5 vs. 2.4 +/- 1.5 pulses/13 h). Prolactin and androstenedione increased between the first and second admissions, with no changes in E(2), cortisol, testosterone, or DHEAS. In conclusion, blockade of P action by mifepristone does not reverse a suppressed LH pulse frequency within 7 days when E(2) concentrations are maintained, suggesting that P withdrawal alone may not explain the luteal-follicular increase of GnRH pulse frequency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609733      PMCID: PMC2758640          DOI: 10.1007/s12020-009-9215-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  49 in total

1.  The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.

Authors:  J D Veldhuis; M L Carlson; M L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

Authors:  J H Liu; G Garzo; S Morris; C Stuenkel; A Ulmann; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

3.  Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.

Authors:  G Schaison; M George; N Lestrat; A Reinberg; E E Baulieu
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

4.  Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.

Authors:  M Filicori; N Santoro; G R Merriam; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

5.  Morphologic response of endometrium to a progesterone receptor antagonist, RU486, in monkeys.

Authors:  M J Koering; D L Healy; G D Hodgen
Journal:  Fertil Steril       Date:  1986-02       Impact factor: 7.329

6.  Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.

Authors:  K M Gross; A M Matsumoto; W J Bremner
Journal:  J Clin Endocrinol Metab       Date:  1987-04       Impact factor: 5.958

7.  Progesterone modulation of pulsatile luteinizing hormone secretion in normal women.

Authors:  M R Soules; R A Steiner; D K Clifton; N L Cohen; S Aksel; W J Bremner
Journal:  J Clin Endocrinol Metab       Date:  1984-02       Impact factor: 5.958

8.  Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.

Authors:  N Reame; S E Sauder; R P Kelch; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

9.  The progesterone antagonist RU 486. A potential new contraceptive agent.

Authors:  L K Nieman; T M Choate; G P Chrousos; D L Healy; M Morin; D Renquist; G R Merriam; I M Spitz; C W Bardin; E E Baulieu
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

10.  Actions of estradiol on discrete attributes of the luteinizing hormone pulse signal in man. Studies in postmenopausal women treated with pure estradiol.

Authors:  J D Veldhuis; W S Evans; A D Rogol; M O Thorner; P Stumpf
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

View more
  1 in total

1.  Persistence of sleep-associated decrease in GnRH pulse frequency in the absence of gonadal steroids.

Authors:  Natalie D Shaw; Sabrina Gill; Helene B Lavoie; Erica E Marsh; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.